YD Bio's H1 2026: Revenue Jumps 315%, but Going Concern Warning and Cash Burn Loom
YDES has more than doubled off its 52-week low of $1.7 on elevated volume (3.0× avg).
Summary
YD Bio's H1 2026 revenue surged 315% to $846K, but the $6.7M net income is a non-cash warrant remeasurement gain. Operational losses widened, cash fell to $2.66M, and the company issued a going concern warning.
Key Events · Earnings and Guidance · YDES
-
Going Concern Warning Issued
Management states substantial doubt about the company's ability to continue as a going concern for at least twelve months, citing recurring operational losses and negative cash flows.
-
Revenue Up 315% to $846K
H1 2026 revenue reached $846,501 versus $204,007 in H1 2025, driven by a single $327,060 order for Fetroja for Injection from the top client.
-
Net Income Is Non-Cash Accounting Gain
Reported net income of $6.7 million is entirely attributable to a $9.8 million non-cash gain from warrant liability remeasurement as the share price declined; operational loss widened to $3.1 million.
-
Cash Burn Accelerates
Cash and cash equivalents fell to $2.66 million from $6.01 million at year-end 2025, with $2.8 million used in operating activities during the six months.
Analysis · YDES · Industrial Applications And Services
YD Bio's first-half 2026 results show a dramatic revenue increase to $846,501, but the reported $6.7 million net income is entirely driven by a $9.8 million non-cash gain from warrant liability remeasurement as the share price fell. Excluding that accounting adjustment, the operational loss widened to $3.1 million. Cash dropped to $2.66 million, and management explicitly states substantial doubt about the company's ability to continue as a going concern. The company needs to raise capital soon, which likely means further dilution for existing shareholders.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1045 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, YDES was trading at $3.71 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $262.8M. The 52-week trading range was $1.70 to $25.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.